Filtered By:
Countries: China Health

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 130538 results found since Jan 2013.

Cerebrolysin for vascular dementia.
CONCLUSIONS: Courses of intravenous Cerebrolysin improved cognition and general function in people living with vascular dementia, with no suggestion of adverse effects. However, these data are not definitive. Our analyses were limited by heterogeneity, and the included papers had high risk of bias. If there are benefits of Cerebrolysin, the effects may be too small to be clinically meaningful. There have been no new studies of Cerebrolysin in vascular dementia since the last Cochrane Review. Cerebrolysin continues to be used and promoted as a treatment for vascular dementia, but the supporting evidence base is weak. Adequa...
Source: Cochrane Database of Systematic Reviews - November 10, 2019 Category: General Medicine Authors: Cui S, Chen N, Yang M, Guo J, Zhou M, Zhu C, He L Tags: Cochrane Database Syst Rev Source Type: research

Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack
CONCLUSIONS: Peroxisome proliferator-activated receptor gamma agonists probably reduce recurrent stroke and total events of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke, and may improve insulin sensitivity and the stabilisation of carotid plaques. Their effects on adverse events are uncertain. Our conclusions should be interpreted with caution considering the small number and the quality of the included studies. Further well-designed, double-blind RCTs with large samples are required to assess the efficacy and safety of PPAR-γ agonists in the secondary prevention of stroke and related vascular...
Source: Cochrane Database of Systematic Reviews - January 10, 2023 Category: General Medicine Authors: Jia Liu Lu-Ning Wang Source Type: research

Effects of traditional Chinese exercise on vascular function in patients with Alzheimer's disease: A protocol for systematic review and network meta-analysis of randomized controlled trials
CONCLUSION: In this study, randomized controlled trials of the effects of TCEs on vascular function in AD patients will be selected to provide evidence-based medical evidence for promoting the application of TCEs by observing the order of advantages and disadvantages of various exercise modalities through network meta-analysis.PMID:36701718 | DOI:10.1097/MD.0000000000032517
Source: Atherosclerosis - January 26, 2023 Category: Cardiology Authors: Jin Li Chen Wang Peizhen Zhang Source Type: research

Anti-vascular endothelial growth factor for neovascular glaucoma
CONCLUSIONS: Anti-VEGFs as an adjunct to conventional treatment could help reduce IOP in NVG in the short term (four to six weeks), but there is no evidence that this is likely in the longer term. Currently available evidence regarding the short- and long-term effectiveness and safety of anti-VEGFs in achieving control of IOP, visual acuity, and complete regression of new iris vessels in NVG is insufficient. More research is needed to investigate the effect of these medications compared with, or in addition to, conventional surgical or medical treatment in achieving these outcomes in NVG.PMID:37010901 | DOI:10.1002/14651858.CD007920.pub4
Source: Cochrane Database of Systematic Reviews - April 3, 2023 Category: General Medicine Authors: Thanitsara Rittiphairoj Gloria Roberti Manuele Michelessi Source Type: research

Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
CONCLUSIONS: The perioperative use of anti-VEGF reduces the risk of late POVCH, probably results in lower early POVCH risk and may improve visual outcomes. It also reduces the incidence of intraoperative retinal breaks. The evidence is very uncertain about its effect on the need for silicone oil tamponade. The reported complications from its use appear to be low. Agreement on variables included and outcome standardisation is required in trials studying vitrectomy for PDR.PMID:37260074 | PMC:PMC10230853 | DOI:10.1002/14651858.CD008214.pub4
Source: Cochrane Database of Systematic Reviews - June 1, 2023 Category: General Medicine Authors: Panagiotis Dervenis Nikolaos Dervenis Jonathan M Smith David Hw Steel Source Type: research

Anti-vascular endothelial growth factor for neovascular glaucoma.
CONCLUSIONS: Currently available evidence is uncertain regarding the long-term effectiveness of anti-VEGF medications, such as intravitreal ranibizumab or bevacizumab or aflibercept, as an adjunct to conventional treatment in lowering IOP in NVG. More research is needed to investigate the long-term effect of these medications compared with, or in addition to, conventional surgical or medical treatment in lowering IOP in NVG. PMID: 32027392 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - February 5, 2020 Category: General Medicine Authors: Simha A, Aziz K, Braganza A, Abraham L, Samuel P, Lindsley KB Tags: Cochrane Database Syst Rev Source Type: research

Epistatic Interaction Between 5-HT1A and Vascular Endothelial Growth Factor Gene Polymorphisms in the Northern Chinese Han Population With Major Depressive Disorder
Conclusions: The interactions between 5-HT1A and VEGF gene polymorphisms may play a key role in the development of MDD in the Northern Chinese Han population.IntroductionMajor depressive disorder (MDD) is one of the most common complex mental disorders, with symptoms that include loss of interest, periodic depression, and thoughts of suicide. Epidemiologic studies have shown that MDD afflicted an estimated 7%–11% of the general population (1, 2); yet, the underlying mechanism of MDD remains unclear. Genetic factors are likely to play a critical role in its etiology with the total contribution of heritability estimat...
Source: Frontiers in Psychiatry - April 15, 2019 Category: Psychiatry Source Type: research

Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress
CONCLUSION: Our present paper provides updated information of natural agents with protective activities on ECs against oxidative stress by activating Nrf2/HO-1. We hope this review will provide some directions for the further development of novel candidate drugs from natural agents for the treatment of AS and other CVDs.PMID:35024180 | PMC:PMC8655139 | DOI:10.1016/j.jare.2021.06.023
Source: Atherosclerosis - January 13, 2022 Category: Cardiology Authors: Qing Zhang Jia Liu Huxinyue Duan Ruolan Li Wei Peng Chunjie Wu Source Type: research

Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.
CONCLUSIONS: Peroxisome proliferator-activated receptor gamma agonists probably reduce recurrent stroke and total events of cardiovascular death, non-fatal myocardial infarction or non-fatal stroke, and may improve insulin sensitivity and the stabilisation of carotid plaques. Their effects on adverse events are uncertain. Our conclusions should be interpreted with caution considering the small number and the quality of the included studies. Further well-designed, double-blind RCTs with large samples are required to assess the efficacy and safety of PPAR-γ agonists in the secondary prevention of stroke and related vascular...
Source: Cochrane Database of Systematic Reviews - December 2, 2017 Category: General Medicine Authors: Liu J, Wang LN Tags: Cochrane Database Syst Rev Source Type: research

Efficacy and safety of sirolimus in the treatment of vascular malformations: A protocol for systematic review and meta-analysis
Conclusion: The conclusion of this study will provide more reliable, evidence-based data for the use of sirolimus in the treatment of vascular malformations. PROSPERO registration number: CRD42020167881.
Source: Medicine - October 2, 2020 Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research

The effect of Chinese herbal medicine combined with western medicine on vascular endothelial function for patients with hypertension: Protocol for a systematic review and meta-analysis
Conclusion: This systematic review will determine whether TCM combined with western medicine provides evidence for effective intervention of vascular endothelial function in patients with essential hypertension. Ethics and dissemination: This systematic review and meta-analysis of randomized controlled trials does not require ethical recognition, and the results of this paper will be published in an open access, internationally influential academic journal. PROSPERO registration number: CRD42019140743
Source: Medicine - December 1, 2019 Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research

Analysis of the effects of Zhenju antihypertensive tablet on efficacy, safety and vascular endothelial function in patients with essential hypertension: A protocol for systematic review and meta-analysis
Conclusion : The conclusion of this study intends to provide evidence for judging the effectiveness and safety of ZJAHC intervention on EH patients and their endothelial function. PROSPERO registration number: PROSPERO CRD42021235309.
Source: Medicine - November 19, 2021 Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research

Severe ischemia after radial artery catheterization: A literature review of published cases
CONCLUSION: Severe hand ischemia following RAC is a rare complication, with the reported incidence of approximately 0.09%. There is no definite predictor for RAC-related hand ischemia, but patients with risk factors are prone to the occurrence of hand ischemia. It's vital to initiate early recognition and proactive strategies for a best practice RAC insertion.PMID:36267019 | DOI:10.1177/11297298221101784
Source: The Journal of Vascular Access - October 21, 2022 Category: Surgery Authors: Ying Ying Xian-Ju Lin Min-Juan Chen Yan Cao Yun-Tai Yao Evidence In Cardiovascular Anesthesia (EICA) Group Source Type: research